Medical Affairs Pharmaceutical Physician Work-related Quality of Life (MAPPWrQoL) Instrument Development and Patient Registry (MAPPWrQoLReg)
Recruiting · NCT05123846 · Observational (researchers observe without assigning treatment) · Lead sponsor: Medialis Ltd.
View the official record on ClinicalTrials.gov →What this trial is about
Existing evidence has shown that medical affairs pharmaceutical physicians (MAPPs), are a core function within the pharmaceutical industry. Despite their expertise, there are ongoing concerns about recognition and respect for the MAPP's role within the pharmaceutical industry. Anecdotal evidence further suggests that this lack of recognition and respect for the valuable contribution of this specialised group of medical doctors may impact their quality of life, resulting in stress, anxiety, depression and occupational burnout. Hence, participants are likely to use NHS services as patients, when experiencing the physical, mental, and emotional issues associated with occupational burnout, an internationally recognised condition (ICD-11 code QD85) resulting from chronic occupational stress. This observational study will recruit participants to contribute data to creating a MAPP work-related participant-reported outcome measure on the impact of work-related performance on quality of life (QoL). The created MAPP work-related participant-reported measure will be used longitudinally with study participants to measure their QoL monthly for 12 months. In total, up to 180 Medical Affairs Pharmaceutical Physicians are expected to be recruited to the study. The study will be conducted in two main phases, involving three online surveys.
Who can take part
Inclusion criteria
- Phase one and Phase two: Participants will be eligible to take part in Phase One based on the following criteria:
- Qualification as a Medical Affairs Pharmaceutical Physician (qualified by medical degree).
- Previous or current work experience within a pharmaceutical company (industry-based).
- The participant can provide informed consent.
- The participant can read, write, and converse in English.
- The participant can comply with the study schedule.
- 18 years and above.
Exclusion criteria
- Non-industry based Medical Affairs Pharmaceutical Physicians
- Not able to comply with the study schedule
- Not able to read, write, and converse in English.
Where it is running
1 location listed.
- Medialis - Oxford, United Kingdom